These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36321982)

  • 41. Investigation of test methods for QC in dual-energy based contrast-enhanced digital mammography systems: II. Artefacts/uniformity, exposure time and phantom-based dosimetry.
    Marshall NW; Cockmartin L; Bosmans H
    Phys Med Biol; 2023 Oct; 68(21):. PubMed ID: 37820686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast cancer diagnosis from contrast-enhanced mammography using multi-feature fusion neural network.
    Qian N; Jiang W; Guo Y; Zhu J; Qiu J; Yu H; Huang X
    Eur Radiol; 2024 Feb; 34(2):917-927. PubMed ID: 37610440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of False-Positive Versus True-Positive Findings on Contrast-Enhanced Digital Mammography.
    Amir T; Hogan MP; Jacobs S; Sevilimedu V; Sung J; Jochelson MS
    AJR Am J Roentgenol; 2022 May; 218(5):797-808. PubMed ID: 34817195
    [No Abstract]   [Full Text] [Related]  

  • 44. Improving the Diagnostic Accuracy of Breast BI-RADS 4 Microcalcification-Only Lesions Using Contrast-Enhanced Mammography.
    Long R; Cao K; Cao M; Li XT; Gao F; Zhang FD; Yu YZ; Sun YS
    Clin Breast Cancer; 2021 Jun; 21(3):256-262.e2. PubMed ID: 33243676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lesion attention guided neural network for contrast-enhanced mammography-based biomarker status prediction in breast cancer.
    Qian N; Jiang W; Wu X; Zhang N; Yu H; Guo Y
    Comput Methods Programs Biomed; 2024 Jun; 250():108194. PubMed ID: 38678959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative evaluation of breast cancer: Contrast-enhanced mammography versus contrast-enhanced magnetic resonance imaging: A systematic review and meta-analysis.
    Shahraki Z; Ghaffari M; Nakhaie Moghadam M; Parooie F; Salarzaei M
    Breast Dis; 2022; 41(1):303-315. PubMed ID: 35754256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement Type at Contrast-enhanced Mammography and Association with Malignancy.
    Kim G; Mehta TS; Brook A; Du LH; Legare K; Phillips J
    Radiology; 2022 Nov; 305(2):299-306. PubMed ID: 35819328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contrast-enhanced Mammography: A Guide to Setting Up a New Clinical Program.
    Kim G; Patel B; Mehta TS; Du L; Mehta RJ; Phillips J
    J Breast Imaging; 2021 May; 3(3):369-376. PubMed ID: 38424777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
    Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
    Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrast-enhanced Mammography: How Does It Work?
    Sensakovic WF; Carnahan MB; Czaplicki CD; Fahrenholtz S; Panda A; Zhou Y; Pavlicek W; Patel B
    Radiographics; 2021; 41(3):829-839. PubMed ID: 33835871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis.
    Pötsch N; Vatteroni G; Clauser P; Helbich TH; Baltzer PAT
    Radiology; 2022 Oct; 305(1):94-103. PubMed ID: 36154284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Performance in Diagnosis and Characterization of Breast Lesions: Contrast-Enhanced Mammography Versus Breast Magnetic Resonance Imaging.
    Açar ÇR; Orguc S
    Clin Breast Cancer; 2024 Aug; 24(6):481-493. PubMed ID: 38777678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contrast-enhanced mammography-guided biopsy: technique and initial outcomes.
    Tang YC; Cheung YC
    Quant Imaging Med Surg; 2023 Aug; 13(8):5349-5354. PubMed ID: 37581028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The diagnostic value of contrast-enhanced 2D mammography in everyday clinical use.
    Neeter LMFH; Raat HPJ; Meens-Koreman SD; van Stiphout RSA; Timmermans SMEC; Duvivier KM; Smidt ML; Wildberger JE; Nelemans PJ; Lobbes MBI
    Sci Rep; 2021 Nov; 11(1):22224. PubMed ID: 34782698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brief communication: The current status of contrast-enhanced mammography in breast imaging.
    Savaria D; Kaushik C
    Clin Imaging; 2024 Sep; 113():110213. PubMed ID: 38852214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contrast-enhanced Mammography: Current Applications and Future Directions.
    Ghaderi KF; Phillips J; Perry H; Lotfi P; Mehta TS
    Radiographics; 2019; 39(7):1907-1920. PubMed ID: 31697627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of True and False Positive Findings on Contrast-Enhanced Mammography.
    Phillips J; U Achibiri J; Kim G; Quintana LM; J Mehta R; S Mehta T
    Acad Radiol; 2022 Nov; 29(11):1672-1681. PubMed ID: 35190261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of contrast-enhanced mammogram as an adjunct to tomosynthesis in evaluation of circumscribed breast lesions.
    Porkodi D; Devimeenal J
    Br J Radiol; 2024 Oct; 97(1162):1696-1705. PubMed ID: 39024041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contamination artifact that mimics in-situ carcinoma on contrast-enhanced digital mammography.
    Gluskin J; Click M; Fleischman R; Dromain C; Morris EA; Jochelson MS
    Eur J Radiol; 2017 Oct; 95():147-154. PubMed ID: 28987661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patient preferences regarding use of contrast-enhanced imaging for breast cancer screening.
    Son D; Phillips J; Mehta TS; Mehta R; Brook A; Dialani VM
    Acad Radiol; 2022 Jan; 29 Suppl 1():S229-S238. PubMed ID: 33846061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.